Fresenius Kabi Pharmaceuticals Holding, Inc. Files Form 25 to Delist and Deregister Contingent Value Rights for APP Pharmaceuticals
3/7/2011 5:27:21 PM
More...
|
Fresenius Kabi Pharmaceuticals Holding, Inc. Files Form 10-K for APP Pharmaceuticals
2/23/2011 9:41:42 AM
More...
|
Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-Q
11/2/2010 10:36:00 AM
More...
|
Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-Q
8/3/2010 9:49:16 AM
More...
|
Fresenius Kabi Pharmaceuticals Holding, Inc. Release: APP Pharmaceuticals To Market Anastrozole Tablets In The U.S.
6/29/2010 7:49:10 AM
More...
|
Fresenius Kabi Pharmaceuticals Holding, Inc. Release: APP Pharmaceuticals to Market Oxaliplatin Injection (Liquid) in the U.S.
6/11/2010 10:08:19 AM
More...
|
Bernhard Hampl, Ph.D. Elected to Serve as Executive Chairman of the Board of Directors of Fresenius Kabi Pharmaceuticals Holding, Inc.
11/3/2009 9:55:10 AM
More...
|
Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-Q
11/3/2009 9:01:17 AM
More...
|
Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-Q
8/4/2009 9:48:22 AM
More...
|
Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-Q
4/30/2009 9:48:45 AM
More...
|
|